Urinary Incontinence
Pipeline by Development Stage
On Market (4)
Approved therapies currently available
Competitive Landscape
33 companies ranked by most advanced pipeline stage
+3 more companies
Trial Timeline
Clinical trial activity over time
Showing 15 of 50 trials with date data
Clinical Trials (50)
Total enrollment: 17,443 patients across 50 trials
A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients
Value of Urodynamic Evaluation
Conveen Optima Urisheaths With Collecting Bags Versus Absorbents
A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.
Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.
Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder
Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women
A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder
Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction
Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1
OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)
A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity
Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
Refractory Urge Incontinence and Botox Injections
Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet
An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence
Bladder Scan of Residual Urine With New Catheter
BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Urge Incontinence Bladder Overactivity Study
DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
IRIS: Incontinence Research Intervention Study
Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients
Injectable Bulking Agent Needle Guide
Evaluation of Non-Invasive Pelvic Floor Neuromuscular Stimulation for Urinary Incontinence After Prostatectomy
An Evaluation of the PureWick™ Male External Catheter Versus an Established Comparator Overnight in the Home Setting for Incontinence in Adult Males
This Study Will Collect Clinical and Patient Reported Satisfaction Data From Males Requiring Urine Output Management Overnight in the Home Setting.
Training for Urinary Leakage Improvement After Pregnancy
This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.
NXT Post-Market Clinical Follow-up
Clinical Study of External Electrical Stimulation for Male Incontinence
Performance and Safety of the PHENIX LIBERTY, a Medical Device for Electrostimulation and Biofeedback, in the Treatment of Pelvic Static Disorders in Women With Urinary Incontinence.
Outcomes of Urinary Incontinence Treatment in Primary Care: APP Co-Management and Electronic Consult
Clinical Trial of New Intermittent Single-use Catheter
Real-World Registry - The Vivally® System
Clinical Trial of New Single-use Compact Intermittent Catheter
Performance of a Single-use Intermittent Micro-hole Zone Catheter
A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence
Study for a Magnetic Endourethral Sphincter Against Stress Urinary Incontinence
An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization
Effects of Pilates Exercises Versus Pelvic Floor Muscle Exercises Among Elderly Women With Urinary Incontinence
Intermittent Catheterisation on the Bladder Mucosa of Healthy Volunteers With a Prototype Micro Hole Zone Catheter
A Pilot Study to Evaluate PureWick for Nocturia
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.